Researchers from the Institute of Industrial Science, The University of Tokyo have developed ultrathin, stretchable facial electrodes that are effectively invisible and cannot be felt when worn. The electrodes reduce the visual discomfort and psychological burden associated with conventional facial sensors, allowing eye movements, facial muscle activity, and brain activity to be measured under more natural conditions. The electrodes could allow future technology to be operated with subtle facial and eye signals.

In the rainforests of the Democratic Republic of Congo, scientists have uncovered a previously unknown species of monkey named Colobus congoensis. The discovery marks only the fifth new monkey species in Africa identified in the past 75 years. Genetic and anatomical analyses confirmed it as a distinct species, separated from its closest relative by 4 to 5 million years of evolution. Found only within a small range of roughly 1,700 square kilometers, the monkey, which is mainly black with striking orange face patches confronts growing pressure from habitat loss and hunting and is being recommended for endangered conservation status.

In preclinical tests, the compound from UC San Diego startup Sinopia Biosciences boosted the standard treatment’s benefits while counteracting debilitating side effects.

 

Scientists have discovered marsupial forelimbs (arms) develop before birth much earlier than previously thought, providing new insights into evolutionary innovation and biology.  

Scientists reveal how cells control the "walking" protein kinesin-1. The discovery could enable treatments for some diseases that cause paralysis, seizures and cognitive deficits. 

MIT engineers found a way to engineer and control the growth of blood vessels by mechanically stretching them. The technology could advance efforts to replace a patient’s damaged or diseased tissue with a healthy, artificially grown version.

Researchers at Uppsala University have discovered a completely new fungal species, which they chose to name after the King of Sweden. The species has been given the Latin name Semicentenialea rex, which means fifty-year anniversary of the King. It is the first known representative of a new class of fungi that will be called Semicentenialomycetes. 

Finding names for new species is a pleasant challenge for all researchers doing this type of research. This particular one was named Semicentenialea rex to pay tribute to King Carl XVI Gustaf of Sweden when he celebrated 50 years on the throne in 2023.

 

“During his reign, the King has worked tirelessly for biodiversity conservation and the sustainable use of our natural resources. What could be better than to have a previously undescribed fungus named after you,” says Anna Rosling, who in connection with the official celebration of the King’s golden jubilee presented a picture and a description of the species to him.

 

A major challenge in cuproptosis-based cancer therapy is achieving tumor-selective activation without relying on external copper administration. Published in Biomedical Analysis, a new study from Guizhou Medical University introduces an iRGD-modified PLGA-PEG nanoparticle system that delivers the copper-chelating agent TPEN directly to tumor cells. By exploiting the high copper levels already present in cancer cells, this approach triggers copper-dependent cell death while reducing potential systemic toxicity associated with metal delivery.